ResultsIQ

ResultsIQ › Latest results › Viyash Scientific Limited

Viyash Scientific Limited Q1 FY26 earnings call summary

NSE: VIYASH · BSE: 512529

Earnings call of 11 Aug 2025, summarised by AI from the filing.

SeQuent adjusted EBITDA margin guided closer to mid-teens this year, Viyash high-teens; PAT growth expected ahead of EBITDA growth.

Key takeaways

  1. Margin guidance SeQuent adjusted EBITDA margin guided closer to mid-teens this year, Viyash high-teens; PAT growth expected ahead of EBITDA growth.
  2. Merger progress CCI and stock exchange approvals received, NCLT filings complete, shareholders' and creditors' meeting on August 30, 2025.
  3. Growth driver Emerging markets grew 25% year-on-year on higher exports, price increases and product mix; Mexico front-end added.
  4. Main risk US policy and tariff changes could affect exports; around 17-18% of combined exposure is to the US market.

Original filing on BSE

Viyash Scientific Limited Q1 FY27 results

As filed: Revenue ₹946 cr, EBITDA ₹178 cr, PAT ₹79.3 cr, EBITDA margin 18.9%.

Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹946 cr). Scored once a year-earlier consolidated quarter exists.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹920 cr, EBITDA ₹184 cr, PAT ₹66.4 cr, EBITDA margin 20.0%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹920 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +11.0% in 30 days (Nifty 500: +3.0%).
  • Q3 FY26: Revenue ₹858 cr, EBITDA ₹176 cr, PAT ₹48.5 cr, EBITDA margin 20.5%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹858 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +11.7% in 30 days (Nifty 500: +2.5%).

Past price moves after results do not indicate future moves. Not a recommendation.

Viyash Scientific Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.